Honokiol and Magnolol: Insights into Their Antidermatophytic Effects.

Adriana Trifan, Andra-Cristina Bostănaru, Simon Vlad Luca, Veronika Temml, Muhammad Akram, Sonja Herdlinger, Łukasz Kulinowski, Krystyna Skalicka-Woźniak, Sebastian Granica, Monika E Czerwińska, Aleksandra Kruk, Hélène Greige-Gerges, Mihai Mareș, Daniela Schuster
Author Information
  1. Adriana Trifan: Department of Pharmacognosy, Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania. ORCID
  2. Andra-Cristina Bostănaru: Laboratory of Antimicrobial Chemotherapy, Faculty of Veterinary Medicine, "Ion Ionescu de la Brad" Iasi University of Life Sciences, 700489 Iasi, Romania.
  3. Simon Vlad Luca: Department of Pharmacognosy, Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania.
  4. Veronika Temml: Department of Pharmaceutical Chemistry, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.
  5. Muhammad Akram: Department of Pharmaceutical Chemistry, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.
  6. Sonja Herdlinger: Department of Pharmaceutical Chemistry, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.
  7. Łukasz Kulinowski: Department of Natural Products Chemistry, Medical University of Lublin, 20-093 Lublin, Poland. ORCID
  8. Krystyna Skalicka-Woźniak: Department of Natural Products Chemistry, Medical University of Lublin, 20-093 Lublin, Poland. ORCID
  9. Sebastian Granica: Microbiota Lab, Centre for Preclinical Studies, Department of Pharmacognosy and Molecular Basis of Phytotherapy, Medical University of Warsaw, 02-097 Warsaw, Poland. ORCID
  10. Monika E Czerwińska: Department of Biochemistry and Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw, 02-097 Warsaw, Poland. ORCID
  11. Aleksandra Kruk: Microbiota Lab, Centre for Preclinical Studies, Department of Pharmacognosy and Molecular Basis of Phytotherapy, Medical University of Warsaw, 02-097 Warsaw, Poland.
  12. Hélène Greige-Gerges: Bioactive Molecules Research Laboratory, Department of Chemistry and Biochemistry, Faculty of Sciences, Section II, Lebanese University, Jdeidet el-Matn B.P. 90656, Lebanon. ORCID
  13. Mihai Mareș: Laboratory of Antimicrobial Chemotherapy, Faculty of Veterinary Medicine, "Ion Ionescu de la Brad" Iasi University of Life Sciences, 700489 Iasi, Romania. ORCID
  14. Daniela Schuster: Department of Pharmaceutical Chemistry, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria. ORCID

Abstract

Dermatophyte infections represent a significant public health concern, with an alarming negative impact caused by unsuccessful therapeutic regimens. Natural products have been highlighted as a promising alternative, due to their long-standing traditional use and increasing scientific recognition. In this study, honokiol and magnolol, the main bioactives from spp. bark, were investigated for their antidermatophytic activity. The antifungal screening was performed using dermatophyte standard strains and clinical isolates. The minimal inhibitory concentration (MIC) and the minimal fungicidal concentration (MFC) were determined in accordance with EUCAST-AFST guidelines, with minor modifications. The effects on ergosterol biosynthesis were assessed in cells by HPLC-DAD. Putative interactions with terbinafine against were evaluated by the checkerboard method. Their impact on cells' viability and pro-inflammatory cytokines (IL-1β, IL-8 and TNF-α) was shown using an ex vivo human neutrophils model. Honokiol and magnolol were highly active against tested dermatophytes, with MIC and MFC values of 8 and 16 mg/L, respectively. The mechanism of action involved the inhibition of ergosterol biosynthesis, with accumulation of squalene in cells. Synergy was assessed for binary mixtures of magnolol with terbinafine (FICI = 0.50), while honokiol-terbinafine combinations displayed only additive effects (FICI = 0.56). In addition, magnolol displayed inhibitory effects towards IL-1β, IL-8 and TNF-α released from lipopolysaccharide (LPS)-stimulated human neutrophils, while honokiol only decreased IL-1β secretion, compared to the untreated control. Overall, honokiol and magnolol acted as fungicidal agents against dermatophytes, with impairment of ergosterol biosynthesis.

Keywords

References

  1. Food Funct. 2019 Sep 1;10(9):6135-6146 [PMID: 31497826]
  2. Arch Pharm Res. 2010 Jan;33(1):61-5 [PMID: 20191344]
  3. J Cell Physiol. 2011 Sep;226(9):2338-49 [PMID: 21660957]
  4. Nat Commun. 2019 Jan 9;10(1):97 [PMID: 30626872]
  5. Front Pharmacol. 2021 Mar 17;12:632767 [PMID: 33815113]
  6. Antimicrob Agents Chemother. 1985 Feb;27(2):252-6 [PMID: 4039119]
  7. Expert Rev Clin Pharmacol. 2017 Feb;10(2):225-237 [PMID: 27868472]
  8. J Appl Microbiol. 2015 Apr;118(4):826-38 [PMID: 25641229]
  9. Molecules. 2019 Jun 06;24(11): [PMID: 31174300]
  10. Fitoterapia. 2018 Jun;127:115-122 [PMID: 29447978]
  11. J Antimicrob Chemother. 2004 Nov;54(5):854-69 [PMID: 15375111]
  12. Immunol Lett. 2016 Oct;178:3-9 [PMID: 27262927]
  13. Front Microbiol. 2019 Sep 19;10:2168 [PMID: 31608026]
  14. Molecules. 2019 Oct 15;24(20): [PMID: 31619024]
  15. J Pharm Sci. 2011 Aug;100(8):3357-3364 [PMID: 21387317]
  16. Lett Appl Microbiol. 2010 Sep;51(3):351-7 [PMID: 20681969]
  17. Mycopathologia. 2017 Feb;182(1-2):5-31 [PMID: 27783317]
  18. Antimicrob Agents Chemother. 2019 Sep 23;63(10): [PMID: 31383665]
  19. Food Funct. 2020 Sep 23;11(9):7946-7959 [PMID: 32832941]
  20. Immunology. 1987 Jul;61(3):289-95 [PMID: 3610211]
  21. Phytomedicine. 2021 Sep;90:153647 [PMID: 34362632]
  22. Cancers (Basel). 2019 Dec 22;12(1): [PMID: 31877856]
  23. Adv Wound Care (New Rochelle). 2013 Sep;2(7):389-399 [PMID: 24527355]
  24. Front Immunol. 2020 Dec 02;11:605644 [PMID: 33343578]
  25. Nat Rev Immunol. 2011 Apr;11(4):275-88 [PMID: 21394104]
  26. J Clin Microbiol. 1999 Oct;37(10):3332-7 [PMID: 10488201]
  27. Front Microbiol. 2020 Jul 14;11:1593 [PMID: 32760372]
  28. Arch Pharm Res. 2000 Feb;23(1):46-9 [PMID: 10728656]
  29. J Ethnopharmacol. 2020 Nov 15;262:113169 [PMID: 32739565]
  30. Fungal Genet Biol. 2019 Nov;132:103255 [PMID: 31330295]
  31. Artif Cells Nanomed Biotechnol. 2018;46(sup1):740-750 [PMID: 29400085]
  32. Int J Nanomedicine. 2021 Jan 26;16:651-665 [PMID: 33536753]
  33. Planta Med. 2018 Nov;84(16):1151-1164 [PMID: 29925102]
  34. Front Microbiol. 2018 May 29;9:1108 [PMID: 29896175]
  35. PLoS One. 2013 Aug 12;8(8):e72203 [PMID: 23951297]
  36. J Appl Microbiol. 2020 Aug;129(2):212-232 [PMID: 32048417]
  37. J Formos Med Assoc. 2021 Jul;120(7):1452-1458 [PMID: 33581965]
  38. PLoS One. 2019 Sep 4;14(9):e0221249 [PMID: 31483823]
  39. Crit Rev Microbiol. 2020 May;46(3):338-357 [PMID: 32608293]
  40. Med Mycol. 2020 Aug 1;58(6):707-720 [PMID: 31773153]
  41. Planta Med. 2011 Jul;77(11):1168-82 [PMID: 21283954]
  42. Mycopathologia. 2017 Feb;182(1-2):143-167 [PMID: 27771883]
  43. Int J Clin Exp Pathol. 2015 Jul 01;8(7):7929-36 [PMID: 26339358]
  44. J Fungi (Basel). 2021 Sep 05;7(9): [PMID: 34575765]
  45. J Ethnopharmacol. 2019 May 23;236:412-442 [PMID: 30818008]
  46. Br J Dermatol. 2017 Nov;177(5):1279-1284 [PMID: 28762471]
  47. Planta Med. 2010 Oct;76(14):1479-91 [PMID: 20533165]
  48. Am J Clin Dermatol. 2003;4(1):39-65 [PMID: 12477372]
  49. Int J Mol Sci. 2020 Aug 25;21(17): [PMID: 32854425]
  50. Br J Dermatol. 1992 Feb;126 Suppl 39:2-7 [PMID: 1543672]

Grants

  1. T 942/Austrian Science Fund FWF

Word Cloud

Created with Highcharts 10.0.0magnololergosterolhonokioleffectsbiosynthesisterbinafineIL-1βimpactusingminimalinhibitoryconcentrationMICfungicidalMFCassessedcellscheckerboardcytokinesIL-8TNF-αhumanneutrophilsHonokioldermatophytessqualeneFICI=0displayedDermatophyteinfectionsrepresentsignificantpublichealthconcernalarmingnegativecausedunsuccessfultherapeuticregimensNaturalproductshighlightedpromisingalternativeduelong-standingtraditionaluseincreasingscientificrecognitionstudymainbioactivessppbarkinvestigatedantidermatophyticactivityantifungalscreeningperformeddermatophytestandardstrainsclinicalisolatesdeterminedaccordanceEUCAST-AFSTguidelinesminormodificationsHPLC-DADPutativeinteractionsevaluatedmethodcells'viabilitypro-inflammatoryshownexvivomodelhighlyactivetestedvalues816mg/LrespectivelymechanismactioninvolvedinhibitionaccumulationSynergybinarymixtures50honokiol-terbinafinecombinationsadditive56additiontowardsreleasedlipopolysaccharideLPS-stimulateddecreasedsecretioncompareduntreatedcontrolOverallactedagentsimpairmentMagnolol:InsightsAntidermatophyticEffectsTrichophytonrubrumassaysynergy

Similar Articles

Cited By (4)